Back

Sandoz wins Canadian approval for generic version of Novo Nordisk's Ozempic

Verifying
  • Sandoz received Health Canada approval to sell generic semaglutide for adults with type 2 diabetes.
  • Semaglutide is Ozempic's key ingredient and is also used in Wegovy.
  • Health Canada granted the authorization on Friday, Sandoz said.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.